Evaluation of an automatic HPLC analyser for thalassemia and haemoglobin variants screening
Author Information
Author(s): R. Galanello, S. Barella, D. Gasperini, L. Perseu, E. Paglietti, 2. Sollaino, L. Paderi, M. G. Pirroni, L. Maccioni, A. Mosca
Primary Institution: Istituto di Clinica Biologia dell'Et Evolutiva, Universit degli Studi di Cagliari
Hypothesis
The new automatic HPLC analyser can accurately and efficiently screen for thalassemia and haemoglobin variants.
Conclusion
The automatic HPLC analyser provides accurate and reproducible results for screening thalassemia and haemoglobin variants, significantly reducing analysis time and costs.
Supporting Evidence
- The analysis time is short (6.5 minutes) and there is good separation between HbA2 values of thalassemia carriers and normals.
- The system can detect and quantitate most haemoglobin variants, potentially eliminating the need for haemoglobin electrophoresis.
- The method is accurate and reproducible, with a high coefficient of variation never greater than 3.
Takeaway
This study shows that a new machine can quickly and accurately check for blood disorders, making it easier for doctors to help patients.
Methodology
The study involved 823 Sardinian adults and 13 known carriers, using a fully automated HPLC system for haemoglobin analysis.
Limitations
The presence of certain haemoglobin variants can interfere with HbA2 measurements, leading to false results.
Participant Demographics
Sardinian adults, including known carriers of haemoglobin variants.
Statistical Information
Confidence Interval
95%
Want to read the original?
Access the complete publication on the publisher's website